| 前收盘价格 | 0.175 |
| 收盘价格 | 0.180 |
| 成交量 | 1,772,800 |
| 平均成交量 (3个月) | 123,859 |
| 市值 | 55,042,804 |
| 市盈率 (P/E TTM) | 20.00 |
| 价格/销量 (P/S) | 0.310 |
| 股市价格/股市净资产 (P/B) | 0.700 |
| 52周波幅 | |
| 股息率 (DY TTM) | 2.00% |
| 营业毛利率 | 1.88% |
| 营业利益率 (TTM) | 2.79% |
| 稀释每股收益 (EPS TTM) | 0.010 |
| 季度收入增长率 (YOY) | -6.50% |
| 季度盈利增长率 (YOY) | -4.40% |
| 总债务/股东权益 (D/E MRQ) | 26.58% |
| 流动比率 (MRQ) | 2.31 |
| 营业现金流 (OCF TTM) | 10.99 M |
| 资产报酬率 (ROA TTM) | 2.30% |
| 股东权益报酬率 (ROE TTM) | 4.94% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (MY) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 看跌 | 混合的 | |
| 股票 | PLABS | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | 2.5 |
| 价格波动 | -1.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.20 |
|
Peterlabs Holdings Bhd is a Malaysia-based company engaged in the manufacturing, distribution, and trading of animal health and nutrition products. It also provides solutions like farm management, technical advisory services, raw material analysis, and feed formulation. The operating segments of the group are Manufacturing which relates to the manufacturing of animal health and nutrition products, and Trading which relates to the trading and distribution of animal health and nutrition products. It offers products like animal feed additives, veterinary pharmaceuticals, injectable products, multi-nutrient and supplements, topical dressings, cleansing agents, and other related products. The company operates in Malaysia and internationally and generates key revenue from the Trading segment. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 66.14% |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| MR BU YAW SENG | 0.200 | - | 2,107,600 | 421,520 |
| 累积净数量 | 2,107,600 | |||
| 累积净值 ($) | 421,520 | |||
| 累积平均购买 ($) | 0.200 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| MR BU YAW SENG | 大股东 | 23 Dec 2024 | 获得 (+) | 400,000 | 0.200 | 80,000 |
| MR BU YAW SENG | 大股东 | 20 Dec 2024 | 获得 (+) | 1,707,600 | 0.200 | 341,520 |
| 日期 | 类型 | 细节 |
|---|---|---|
| 20 Dec 2024 | 公告 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR BU YAW SENG |
| 29 Nov 2024 | 公告 | Quarterly rpt on consolidated results for the financial period ended 30/09/2024 |
| 股息率 (DY TTM) | 2.00% |
| 4年平均股息收益率 | 1.83% |
| 股息支付比率 | 32.26% |
| 预计下次股息支付 | Mar 2025 |
| 除息日 | 公告日期 | 支付日期 | 详情 |
|---|---|---|---|
| 21 Mar 2024 | 06 Mar 2024 | 29 Mar 2024 | 0.004 现金 |
| 14 Jul 2022 | 20 Jun 2022 | 22 Jul 2022 | 0.006 现金 |
| 01 Oct 2020 | 17 Sep 2020 | 09 Oct 2020 | 0.01 现金 |
每年股息收益率
| 年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
|---|---|---|---|
| 2024 | 0.004 | 1 | 2.00 |
| 2022 | 0.006 | 1 | 3.08 |
| 2020 | 0.010 | 1 | 4.26 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合